TFM
REGN icon

TFC Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History

TFC Financial Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.4K Hold
104
– – 0.01% 224
2025
Q4 		$80.3K Buy
104
+1
+1% +$679 0.01% 233
2025
Q3 		$57.9K Buy
103
+1
+1% +$565 0.01% 257
2025
Q2 		$53.5K Sell
102
-100
-50% -$55.8K 0.01% 252
2025
Q1 		$128K Sell
202
-70
-26% -$48.1K 0.02% 162
2024
Q4 		$194K Buy
272
+8
+3% +$6.71K 0.03% 128
2024
Q3 		$278K Hold
264
– – 0.04% 111
2024
Q2 		$277K Buy
264
+1
+0.4% +$969 0.05% 97
2024
Q1 		$253K Hold
263
– – 0.05% 99
2023
Q4 		$231K Hold
263
– – 0.05% 103
2023
Q3 		$216K Hold
263
– – 0.05% 98
2023
Q2 		$189K Buy
263
+1
+0.4% +$771 0.05% 114
2023
Q1 		$215K Buy
262
+1
+0.4% +$754 0.06% 99
2022
Q4 		$188K Hold
261
– – 0.05% 97
2022
Q3 		$180K Buy
261
+160
+158% +$101K 0.06% 95
2022
Q2 		$60K Buy
101
+1
+1% +$650 0.02% 190
2022
Q1 		$70K Hold
100
– – 0.02% 182
2021
Q4 		$63K Buy
100
+99
+9,900% +$60.9K 0.02% 201
2021
Q3 		$1K Hold
1
– – ﹤0.01% 537
2021
Q2 		$1K Hold
1
– – ﹤0.01% 541
2021
Q1 		$0 Hold
1
– – ﹤0.01% 590
2020
Q4 		$0 Hold
1
– – ﹤0.01% 585
2020
Q3 		$1K Buy
+1
New +$606 ﹤0.01% 486

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TFC Financial Management's REGN Position: Q1 2026 in Review

TFC Financial Management held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 104 shares worth $80.4K. The position accounts for 0.01% of the portfolio, ranked #224.

TFC Financial Management first reported a position in REGN in Q3 2020 and has held it in 23 quarters since. The position peaked at $278K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • TFC Financial Management held 104 shares of Regeneron Pharmaceuticals worth $80.4K as of Q1 2026.
  • TFC Financial Management left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.01% of TFC Financial Management's portfolio in Q1 2026, its #224 holding.
  • TFC Financial Management first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • TFC Financial Management's Regeneron Pharmaceuticals position peaked at $278K in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.